Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is a Phase I study using vinblastine and sirolimus in patients with relapsed solid
tumors including selected brain tumors and lymphoma. The investigators hypothesis is that the
combination administration of weekly vinblastine and sirolimus is safe.